This Article Full Text Full Text (PDF) eLetters: Submit a response to this article Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article link to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Scurr, M. Articles by Judson, I. Search for Related Content PubMed PubMed Citation Articles by Scurr, M. Articles by Judson, I.

How to Treat the Ewing’s Family of Sarcomas in Adult Patients

Department of Cancer Therapeutics, Institute of Cancer Research, Sutton, Surrey, United Kingdom; Sarcoma Unit, Royal Marsden Hospital, London, United Kingdom

Key Words. Ewing’s sarcoma • Adult Prognosis • Survival

Correspondence: Michelle Scurr, B.Med., F.R.A.C.P., CR-UK Centre for Cancer Therapeutics, Drug Development Unit, Institute of Cancer Research, Sycamore House, Downs Road, Sutton, Surrey, SM2 5PT, United Kingdom. Telephone: 44-0-20-8722-4302; Fax: 020-8642-7979; e-mail: michelle.scurr{at}icr.ac.uk

Ewing’s sarcoma, peripheral primitive neuroectodermal tumor, and Askin’s tumor comprise a single family of tumors, the Ewing’s family of tumors, which is characterized by chromosomal translocation. Ewing’s sarcoma is known as a malignancy of childhood, but with a median age of 15 years at diagnosis, it should equally be regarded as a malignancy of adolescence and young adulthood. There is much controversy regarding the role of age at diagnosis, with some studies showing older age to be associated with poorer outcome and others showing no association between age and survival. This has led to uncertainty in how best to manage nonpediatric patients with Ewing’s sarcoma. This article examines whether age does affect outcome and treatment in this group of tumors.

This article has been cited by other articles:

				C. Ma, K. A. Bower, G. Chen, X. Shi, Z.-J. Ke, and J. Luo Interaction between ERK and GSK3{beta} Mediates Basic Fibroblast Growth Factor-induced Apoptosis in SK-N-MC Neuroblastoma Cells J. Biol. Chem., April 4, 2008; 283(14): 9248 - 9256. [Abstract] [Full Text] [PDF]

				K. M. Skubitz and D. R. D'Adamo Sarcoma Mayo Clin. Proc., November 1, 2007; 82(11): 1409 - 1432. [Abstract] [Full Text] [PDF]